We use cookies to ensure that we give you the best experience on our website Learn more

Home

Saved research

Submission

Our experience with acarbose in pregnancy diabetes

Submitted

0 Views
0 Downloads
0 Saves

Presentation

thumbnail

Abstract

Aim: To study the effect of adding locally acting acarbose along with insulin in controlling difficult to control Post Prandial Blood Glucose (PPBG) in Pregnant Diabetics (PD). Background Postprandial blood sugar raise is the first to occur in GDM and in many cases it is the one which becomes difficult to control. The raised PP BS can be effectively controlled by increasing the dose of short acting insulin. Materials and method: Out of 171 pregnant diabetics (PDs) between the period Jan to Dec 2015 from our centre we selected 52 PDs who were entering 28 weeks of gestation. With treatment still the PPBS >160mg/dl ,either in the morning ,afternoon or night . Their insulin requirement was more than 40 units/day. Conclusion: Acarbose is a better option who require more than 40 units/day. Can be combined with insulin, and the variability is also less, HbA1c is better controlled, insulin requirement is not more, chance of LSCS is lesser and they deli near normal weight babies. So it is logical to conclude that Acarbose addition reduces the neonatal CVD .

Datasets

No datasets are available for this submission.

License

No license information is available for this submission.

Morressier

Company

Legal

Follow us

© Copyright 2020 Morressier GmbH. All rights reserved.

Morressier

© Copyright 2020 Morressier GmbH.
All rights reserved.